The Recall Desk
SevereFDA (Devices)·Z-0883-2023·Announced 2023-01-18

Philips Trilogy 100 and 200 Ventilators Recalled for Foam Separation Risk

Silicone foam in some Philips Trilogy 100 and 200 ventilators may separate and block the air inlet, potentially reducing therapy delivery. This is an FDA Class I recall.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: FDA Class I recalls require a minimum severity score of 4. Although no illnesses or injuries have been reported, the potential for silicone foam to block the air inlet of a ventilator presents a significant risk to patients dependent on these life-support devices.

Plain-English summary

Philips Respironics is recalling some Trilogy 100 and Trilogy 200 ventilators. The silicone sound abatement foam installed in these devices may separate from the plastic backing to which it is attached. If separation occurs, the foam could potentially block the air inlet.

A blocked air inlet could result in a reduction in delivered therapy volume or pressure and could cause the device to alarm. This affects specific serial numbers across multiple model variations of the Trilogy 100 and Trilogy 200 device lines.

These ventilators were distributed nationwide in the United States and globally to Australia, Brazil, Canada, China, Germany, Japan, Korea, and Latin America, totaling 537 devices. Patients using affected devices should contact Philips Respironics for guidance on replacement or corrective action.

The recalled product

Product
Philips Trilogy 200 Ventilator, Model Numbers 1040005, U1040005, 1040005B, U1040005B, CA1032800B, CA1032800, KO1032800, 1032800, R1032804TP, R1032804B, R1032804TPV, 1032804B
Manufacturer
Philips Respironics, Inc.
Hazard
  • foam-separation
  • air-inlet-blockage
  • therapy-volume-reduction

Distribution

Distributed nationwide across the United States.